| Application no. and date | 15724438.5 (espacenet) (Federated) (European Patent Register), 20150506 | | Patent/reg. no. and date | DK/EP 3139925, 20211201 | | Publication date | 20170315 | | Priority no. and date | US 201461989240 P, 20140506 | | EP pub. no. and date |
EP 3139925 20170315 | | Effective date | | | Applicant/owner | NEUROCRINE BIOSCIENCES, INC., 12780 El Camino Real
San Diego, CA 92130, US | | Applicant ref. no. | V435972DK00 | | Inventor | O'BRIEN, Christopher, F., 12780 El Camino Real
San Diego, California 92130, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/473 (2006.01) , A61P 25/00 (2006.01) , A61P 25/14 (2006.01) , A61P 43/00 (2006.01) | | Title | Valbenazin-doseringssystem til behandling af hyperkinetiske bevægelsesforstyrrelser | | Int. application no. | US2015029519 | | Int. publication no. | WO2015171802 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
